Pretreatment prognostic factors for survival in patients with advanced urothelial tumors treated in a phase I/II trial with paclitaxel, cisplatin, and gemcitabine
Joaquim Bellmunt, Joan Albanell, Luis Paz-Ares, Miguel A. Climent, Jose L. González-Larriba, Joan Carles, Juan J. de la Cruz, Vicente Guillem, Eduardo Díaz-Rubio, Hernan Cortés-Funes, José BaselgaVolume:
95
Year:
2002
Language:
english
Pages:
7
DOI:
10.1002/cncr.10762
File:
PDF, 74 KB
english, 2002